appendicitis: challenges in management

24
Appendicitis: Challenges in Management George W. Holcomb, III, M.D., MBA Children’s Mercy Hospital Kansas City, MO

Upload: kimn

Post on 31-Jan-2016

56 views

Category:

Documents


0 download

DESCRIPTION

Appendicitis: Challenges in Management. George W. Holcomb, III, M.D., MBA Children’s Mercy Hospital Kansas City, MO. Questions. Laparoscopy vs open for acute appendicitis? Laparoscopy vs open for perforated appendicitis? How do we define perforation? - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Appendicitis: Challenges in Management

Appendicitis:Challenges in Management

George W. Holcomb, III, M.D., MBAChildren’s Mercy Hospital

Kansas City, MO

Page 2: Appendicitis: Challenges in Management

Questions

• Laparoscopy vs open for acute appendicitis?

• Laparoscopy vs open for perforated appendicitis?

• How do we define perforation?

• Optimal antibiotic management for perforated appendicitis?

• Management of patient presenting with abscess?

• SSULS appendectomy vs 3 port laparoscopic appendectomy?

Page 3: Appendicitis: Challenges in Management

Laparoscopy vs Open Appendectomy

Acute Appendicitis

• Less wound infx with laparoscopy

• Stapler vs cautery/endo loop technique

Page 4: Appendicitis: Challenges in Management

Laparoscopy vs Open Appendectomy

Perforated Appendicitis

• Far fewer (almost none) wound infx with laparoscopic approach

• Allows surgeon to suction/irrigate under direct visualization

• Less small bowel obstruction (SBO)

Page 5: Appendicitis: Challenges in Management

Adhesive Small Bowel Obstruction After Appendectomy in Children: Comparison

Between the Laparoscopic and Open Approach

Jan 98-June 05: 1105 Appendectomies-447 Open, 628 Lap.

AAP 2006AAP 2006J Pediatr Surg 42:939-942, 2007J Pediatr Surg 42:939-942, 2007

Page 6: Appendicitis: Challenges in Management

Laparoscopic versus Open Appendectomy(1105 Patients)

1998-2005Laparoscopic (n = 628) Open (n = 477) P value

Age (years) 11.0 +/- 3.7 9.2 +/- 5.1 p > 0.05

Gender (M/F) 355/273 301/176 p > 0.05

SBO 1 (0.2%) 7 (1.5%) p = 0.01

Perforated appendicitis 186 192

Mean time to SBO 8 days 58 days

Median follow-up (years) 3.5 (0.8 – 6.5) 4.9 (0.9 – 8.3)

AAP, 2006AAP, 2006J Pediatr Surg 42:939-942, 2007J Pediatr Surg 42:939-942, 2007

Page 7: Appendicitis: Challenges in Management

SBO After Perforated Appendicitis (1105 Patients)

1998-2005

Laparoscopic Open P value

Perforated appendicitis 186 192

SBO 1 (0.5%) 6 (3.1%) p = 0.03

AAP, 2006AAP, 2006J Pediatr Surg 42:939-942, 2007J Pediatr Surg 42:939-942, 2007

Page 8: Appendicitis: Challenges in Management

How Do We Define Perforation?

Stool in abdomenHole in appendix

Page 9: Appendicitis: Challenges in Management

Definition of Perforated Appendicitis(Hole in appendix, fecalith in abdomen)

Impact of Strict Definition of Perforation on Abscess Rate

(2003-2007)

Before definition

(292 Pts)

After definition

(388 Pts)

Acute appendicitis Abscess rate

1.7%

Abscess rate

0.8%

Before definition

(131 Pts)

After definition

(161 Pts)

Perforated appendicitis Abscess rate

14.0%

Abscess rate

18.0%

PAPS, 2008PAPS, 2008J Pediatr Surg 43:2242-2245, 2008J Pediatr Surg 43:2242-2245, 2008

Page 10: Appendicitis: Challenges in Management

What is the Optimal Antibiotic Management for Perforated

Appendicitis?

Page 11: Appendicitis: Challenges in Management

Prospective Randomized TrialProspective Randomized TrialCeftriaxone/Metronidazole vs AGCCeftriaxone/Metronidazole vs AGC

• Under 18 years of age

• Perforated appendicitis at the time of appendectomy Stool in the abdomen Hole in the appendix

Exclusion Criteria• Known allergy to one of the medications

Page 12: Appendicitis: Challenges in Management

ResultsResultsOutcomes

WBC (x103) 9.4 +/- 3.9 9.9 +/- 4.4 0.56

LOS (Days) 6.27 +/- 2.5 6.20 +/- 3.2 0.850.85

IV Tx (Days) 6.0 +/- 1.5 6.2 +/- 1.1 0.480.48

Abscess (%) 20.4% 16.3% 0.79

CMCM AGCAGC PP value value

AAP, 2007AAP, 2007J Pediatr Surg 43:79-82, 2007J Pediatr Surg 43:79-82, 2007

Page 13: Appendicitis: Challenges in Management

Conclusions

• There is no difference in infectious complications, recovery or defervescence after perforated appendicitis between Ceftriaxone/MetronidazoleCeftriaxone/Metronidazole and AGC

• Ceftriaxone/MetronidazoleCeftriaxone/Metronidazole is more cost-effective than AGC

AAP, 2007AAP, 2007J Pediatr Surg 43:981-985, 2008J Pediatr Surg 43:981-985, 2008

Page 14: Appendicitis: Challenges in Management

How do we manage the child presenting with an abscess due to ruptured

appendicitis?

Page 15: Appendicitis: Challenges in Management

Prospective Randomized TrialInitial Laparoscopic Appendectomy vs Initial Non-operative

Management for Patients Presenting with Appendicitis and Abscess

Patient Characteristics at the Time of AdmissionInitial

operation

(n = 20)

Initial non-operative management (n = 20)

P value

Age (y) 10.1 +/- 4.2 8.8 +/- 4.2 .31

Weight (kg) 37.0 +/- 16.2 37.1 +/- 20.8 .98

Body mass index (kg/cm2) 18.0 +/- 4.5 19.5 +/- 5.5 .39

White blood cell count 17.4 +/- 6.6 16.9 +/- 6.8 .84

Maximum temperature 37.8 +/- 1.0 37.7 +/- 0.9 .95

Maximum axial area of abscess (cm2) 29.2 +/- 29.7 26.2 +/- 21.1 .75

APSA, 2009APSA, 2009J Pediatr Surg 45:236-240, 2010J Pediatr Surg 45:236-240, 2010

Page 16: Appendicitis: Challenges in Management

Prospective Randomized TrialInitial Laparoscopic Appendectomy vs Initial Non-operative Management for

Patients Presenting with Appendicitis and Abscess

Initial operation

(n = 20)

Initial non-operative management

(n = 20)

P value

Operation time (min) 62.1 +/- 38.7 42.0 +/- 45.5 .06Total length of hospitalization (d)

6.5 +/- 3.8 6.7 +/- 6.6 .92

Recurrent abscess after initial treatment

20% 25% 1.0

Doses of narcotics 9.7 +/- 4.0 7.1 +/- 15.8 .47Total health care visits 2.8 +/- 1.1 4.1 +/- 1.0 <.001No. of CT scans 1.5 +/- 0.7 2.1 +/- 1.1 0.4Total charges $44,195 +/-

$19,384$41,687 +/- $18,483 .68

APSA, 2009APSA, 2009J Pediatr Surg 45:236-240, 2010J Pediatr Surg 45:236-240, 2010

Page 17: Appendicitis: Challenges in Management

Prospective Randomized Trial

Conclusion

There is no difference in outcomes b/w initial laparoscopic operation vs initial non-operative management followed by laparoscopic interval appendectomy for patients presenting with a well-defined abscess due to perforated appendicitis.

APSA, 2009APSA, 2009J Pediatr Surg 45:236-240, 2010J Pediatr Surg 45:236-240, 2010

Page 18: Appendicitis: Challenges in Management

Can patients with perforated appendicitis be discharged prior to

postoperative day 5?

Discharge Criteria

• Afebrile x 24 hrs.

• Regular diet

Page 19: Appendicitis: Challenges in Management

Prospective Randomized Trial

• IV vs IV/PO antibiotics for perforated appendicitis

• 102 patients

• Definition of perforated appendicitis

• IV/PO arm of study (7 days) vs minimum IV antibiotics of 5 days

Page 20: Appendicitis: Challenges in Management

Prospective Randomized Trial Patient Demographics

IV (n=52) IV/PO (n=50) P value

Mean age (years) 9.7 +/-4.2 10.1 +/- 4.6 0.63

Mean weight (kg) 41.2 +/-23.3 43.2 +/- 24.1 0.88

Male (%) 60 60 0.62

Mean maximum temperature on admission (oC)

37.9 +/- 1.0 38.1 +/- 1.0 0.53

Mean duration of symptoms (days)

2.6 +/- 1.3 3.0 +/- 1.5 0.36

AAP, 2009 AAP, 2009 Accepted, J Pediatr Surg Accepted, J Pediatr Surg

Page 21: Appendicitis: Challenges in Management

Prospective Randomized Trial Clinical Outcomes

IV (n=52 IV/PO (n=50 P value

Mean operative time (min) 41:06+/-15:36 46:30+/-19:42 0.13

Mean time to regular diet (min)

68:00+/-35:06 61:42+/-32:12 0.36

Mean length of stay after operation (min)

6:06+/-2:00 4:48 +/-2:36 0.01

Total visits 3.1 +/-1.4 3.1+/-1.2 1.0

Postoperative abscess rate (%) 19 20 1.0

AAP, 2009 AAP, 2009 Accepted, J Accepted, J Pediatr SurgPediatr Surg

Page 22: Appendicitis: Challenges in Management

Conclusion

42% (42/100) of patients in the

IV/PO antibiotic group could be

discharged before day 5 using

discharge criteria of afebrile and

tolerating a regular diet.

Page 23: Appendicitis: Challenges in Management

SSULS Appendectomy

Page 24: Appendicitis: Challenges in Management

QUESTIONS

www.centerforprospectiveclinicaltrials.com

www.cmhcenterforminimallyinvasivesurgery.com